Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Stemtech (STEK) Gains from Investment Securities (2020 - 2023)

Stemtech's Gains from Investment Securities history spans 1 years, with the latest figure at $1.6 million for Q4 2023.

On a quarterly basis, Gains from Investment Securities changed N/A to $1.6 million in Q4 2023 year-over-year; TTM through Sep 2024 was $1.6 million, a N/A change, with the full-year FY2023 number at $1.6 million, changed N/A from a year prior.
Gains from Investment Securities hit $1.6 million in Q4 2023 for Stemtech, up from -$1.6 million in the prior quarter.
Over the last five years, Gains from Investment Securities for STEK hit a ceiling of $1.6 million in Q4 2023 and a floor of -$1.6 million in Q3 2023.